ATL was observed to bind with glycan no. 473, which has Lewis X antigen (Fucα1-2Galβ1-4(Fucα1-3)GlcNAcβ-) at the terminal position of a fucosylated N-glycan and is being employed as a bladder cancer marker [32]. Here, FUT4 is linked to urinary bladder carcinoma.